speb/financial-data huggingface dataset:
FEMY balance_sheet (quarterly, 2025-06-30) — Receivables: 254584.00
FEMY income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 29559.00
FEMY income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 214897.00
FEMY income_statement (quarterly, 2025-06-30) — Research And Development: 1414429.00
FEMY balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -137681018.00
FEMY income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 984977.00
FEMY income_statement (quarterly, 2025-06-30) — Selling General And Administration: 2601949.00
FEMY balance_sheet (quarterly, 2025-06-30) — Share Issued: 1634631.00
FEMY cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 181971.00
FEMY balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 1507435.00
FEMY balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 1451797.00
FEMY income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
FEMY income_statement (quarterly, 2025-06-30) — Tax Provision: 0.00
FEMY income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
FEMY balance_sheet (quarterly, 2025-06-30) — Total Assets: 13780409.00
FEMY balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 1507435.00
FEMY balance_sheet (quarterly, 2025-06-30) — Total Debt: 7852300.00
FEMY balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 1507435.00
FEMY income_statement (quarterly, 2025-06-30) — Total Expenses: 4260834.00
FEMY balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 12272974.00
FEMY balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 4029429.00
FEMY balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 1309367.00
FEMY income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -3851566.00
FEMY balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 5861.00
FEMY balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 60000.00
FEMY balance_sheet (quarterly, 2025-06-30) — Work In Process: 1567202.00
FEMY balance_sheet (quarterly, 2025-06-30) — Working Capital: -1212627.00
FEMY income_statement (quarterly, 2025-09-30) — +Operating Expense: 4089324.00
FEMY income_statement (quarterly, 2025-09-30) — +Total Revenue: 729394.00
FEMY balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 2173883.00
FEMY balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 572199.00
FEMY balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -3956987.00
FEMY balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 139717336.00
FEMY cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 13675.00
FEMY cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 13675.00
FEMY income_statement (quarterly, 2025-09-30) — Basic Average Shares: 2050759.00
FEMY income_statement (quarterly, 2025-09-30) — Basic EPS: -2.00
FEMY cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 3218067.00
FEMY cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -239816.00
FEMY balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 1643217.00
FEMY balance_sheet (quarterly, 2025-09-30) — Capital Stock: 47420.00
FEMY balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 4569038.00
FEMY balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 4569038.00
FEMY cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 6978162.00
FEMY cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -239816.00
FEMY cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -5387375.00
FEMY cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -1101759.00
FEMY cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: -24291.00
FEMY cash_flow (quarterly, 2025-09-30) — Change In Inventory: -551236.00
FEMY cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -128110.00
FEMY cash_flow (quarterly, 2025-09-30) — Change In Payable: -1101759.00
FEMY cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -1126050.00
FEMY cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 118326.00
FEMY cash_flow (quarterly, 2025-09-30) — Change In Receivables: -317615.00
FEMY cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -2004685.00
FEMY cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -317615.00
FEMY cash_flow (quarterly, 2025-09-30) — Changes In Cash: 1350971.00
FEMY balance_sheet (quarterly, 2025-09-30) — Common Stock: 47420.00
FEMY balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 4556251.00
FEMY cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 7998826.00
FEMY balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 687462.00
FEMY income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 293838.00
FEMY balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 764772.00
FEMY balance_sheet (quarterly, 2025-09-30) — Current Assets: 12246900.00
FEMY balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 494954.00
FEMY balance_sheet (quarterly, 2025-09-30) — Current Debt: 6783843.00
FEMY balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 7278797.00
FEMY balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 10541684.00
FEMY balance_sheet (quarterly, 2025-09-30) — Current Notes Payable: 276489.00
FEMY cash_flow (quarterly, 2025-09-30) — Depreciation: 197401.00
FEMY cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 211076.00
FEMY income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 85697.00
FEMY cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 211076.00
FEMY income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 85697.00
FEMY income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 2050759.00
FEMY income_statement (quarterly, 2025-09-30) — Diluted EPS: -2.00
FEMY income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -4194821.00
FEMY income_statement (quarterly, 2025-09-30) — EBIT: -3662748.00
FEMY income_statement (quarterly, 2025-09-30) — EBITDA: -3451672.00
FEMY cash_flow (quarterly, 2025-09-30) — End Cash Position: 4569038.00
FEMY cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 6978162.00
FEMY balance_sheet (quarterly, 2025-09-30) — Finished Goods: 2251483.00
FEMY cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -5627191.00
FEMY cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: 0.00
FEMY income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 1477800.00
FEMY balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 130041.00
FEMY balance_sheet (quarterly, 2025-09-30) — Gross PPE: 7125396.00
FEMY income_statement (quarterly, 2025-09-30) — Gross Profit: 435556.00
FEMY cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 0.00
FEMY income_statement (quarterly, 2025-09-30) — Interest Expense: 532073.00
FEMY income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 532073.00
FEMY income_statement (quarterly, 2025-09-30) — Interest Income: 17315.00
FEMY income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 17315.00
FEMY balance_sheet (quarterly, 2025-09-30) — Interest Payable: 350338.00
FEMY balance_sheet (quarterly, 2025-09-30) — Inventory: 5783974.00
FEMY balance_sheet (quarterly, 2025-09-30) — Invested Capital: 11340094.00
FEMY cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -239816.00
FEMY cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 7998826.00
FEMY balance_sheet (quarterly, 2025-09-30) — Leases: 1238886.00
FEMY balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 1148263.00
FEMY balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 1148263.00
FEMY balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 3779703.00
FEMY cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 7998826.00
FEMY balance_sheet (quarterly, 2025-09-30) — Net Debt: 2214805.00
FEMY income_statement (quarterly, 2025-09-30) — Net Income: -4194821.00
FEMY income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -4194821.00
FEMY income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -4194821.00
FEMY income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -4194821.00
FEMY income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -4194821.00
FEMY cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -4194821.00
FEMY income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -4194821.00
FEMY cash_flow (quarterly, 2025-09-30) — Net Intangibles Purchase And Sale: -45483.00
FEMY income_statement (quarterly, 2025-09-30) — Net Interest Income: -514758.00
FEMY income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -514758.00
FEMY cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -930132.00
FEMY balance_sheet (quarterly, 2025-09-30) — Net PPE: 3168409.00
FEMY cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -194333.00
FEMY balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 4426210.00
FEMY income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -3451672.00
FEMY income_statement (quarterly, 2025-09-30) — Normalized Income: -4194821.00
FEMY cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -5387375.00
FEMY cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 0.00
FEMY income_statement (quarterly, 2025-09-30) — Operating Income: -3653768.00
FEMY income_statement (quarterly, 2025-09-30) — Operating Revenue: 729394.00
FEMY balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 2365118.00
FEMY balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 1321689.00
FEMY balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 6507354.00
FEMY balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 60543.00
FEMY balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 6727334.00
FEMY income_statement (quarterly, 2025-09-30) — Other Gand A: 1477800.00
FEMY income_statement (quarterly, 2025-09-30) — Other Income Expense: -26295.00
FEMY cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 426541.00
FEMY balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 744803.00
FEMY balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 43955.00
FEMY income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -26295.00
FEMY balance_sheet (quarterly, 2025-09-30) — Other Properties: 1419345.00
FEMY balance_sheet (quarterly, 2025-09-30) — Payables: 2173883.00
FEMY balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 2938655.00
FEMY balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 263689.00
FEMY income_statement (quarterly, 2025-09-30) — Pretax Income: -4194821.00
FEMY cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 429.00
FEMY balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
FEMY cash_flow (quarterly, 2025-09-30) — Purchase Of Intangibles: -45483.00
FEMY cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -194333.00
FEMY balance_sheet (quarterly, 2025-09-30) — Raw Materials: 2188853.00
FEMY balance_sheet (quarterly, 2025-09-30) — Receivables: 572199.00
FEMY income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 168459.00
FEMY income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 211076.00
FEMY income_statement (quarterly, 2025-09-30) — Research And Development: 1382022.00
FEMY balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -141875839.00
FEMY income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 1143805.00
FEMY income_statement (quarterly, 2025-09-30) — Selling General And Administration: 2621605.00
FEMY balance_sheet (quarterly, 2025-09-30) — Share Issued: 2370979.00
FEMY cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 174514.00
FEMY balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 4556251.00
FEMY balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 4426210.00
FEMY income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
FEMY income_statement (quarterly, 2025-09-30) — Tax Provision: 0.00
FEMY income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
FEMY balance_sheet (quarterly, 2025-09-30) — Total Assets: 16290153.00
FEMY balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 4556251.00
FEMY balance_sheet (quarterly, 2025-09-30) — Total Debt: 8427060.00
FEMY balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 4556251.00
FEMY income_statement (quarterly, 2025-09-30) — Total Expenses: 4383162.00
FEMY balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 11733902.00
FEMY balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 4043253.00
FEMY balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 1192218.00
FEMY income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -3653768.00
FEMY balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 5861.00
FEMY balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 60000.00
FEMY balance_sheet (quarterly, 2025-09-30) — Work In Process: 1343638.00
FEMY balance_sheet (quarterly, 2025-09-30) — Working Capital: 1705216.00
FEMY income_statement (annual, 2025-12-31) — +Operating Expense: 19009582.00
FEMY income_statement (quarterly, 2025-12-31) — +Operating Expense: 5132990.00
FEMY income_statement (annual, 2025-12-31) — +Total Revenue: 2293313.00
FEMY income_statement (quarterly, 2025-12-31) — +Total Revenue: 813387.00
FEMY balance_sheet (annual, 2025-12-31) — Accounts Payable: 1830124.00
FEMY balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 1830124.00
FEMY balance_sheet (annual, 2025-12-31) — Accounts Receivable: 616600.00
FEMY balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 616600.00
FEMY balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -3802940.00
FEMY balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -3802940.00
FEMY balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 146449576.00
FEMY balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 146449576.00
FEMY balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -14013.00
FEMY balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -14013.00
FEMY cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 46175.00
FEMY cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 16711.00
FEMY cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 46175.00
FEMY cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 16711.00
FEMY income_statement (annual, 2025-12-31) — Basic Average Shares: 1977460.00
FEMY income_statement (annual, 2025-12-31) — Basic EPS: -9.40
FEMY cash_flow (annual, 2025-12-31) — Beginning Cash Position: 3451761.00
FEMY cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 4569038.00
FEMY cash_flow (annual, 2025-12-31) — Capital Expenditure: -630098.00
FEMY cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -196715.00
FEMY balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 1518100.00
FEMY balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 1518100.00
FEMY balance_sheet (annual, 2025-12-31) — Capital Stock: 59720.00
FEMY balance_sheet (quarterly, 2025-12-31) — Capital Stock: 59720.00
FEMY balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 9266353.00
FEMY balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 9266353.00
FEMY balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 9266353.00
FEMY balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 9266353.00
FEMY cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 25135255.00
FEMY cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 9079270.00
FEMY cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -630098.00
FEMY cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -196715.00
FEMY cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -18690565.00
FEMY cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -4185240.00
FEMY cash_flow (annual, 2025-12-31) — Change In Account Payable: 334829.00
FEMY cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -321574.00
FEMY cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 474724.00
FEMY cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 597312.00
FEMY cash_flow (annual, 2025-12-31) — Change In Inventory: -2693926.00
FEMY cash_flow (quarterly, 2025-12-31) — Change In Inventory: 43725.00
FEMY cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -541145.00
FEMY cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -124601.00
FEMY cash_flow (annual, 2025-12-31) — Change In Payable: 334829.00
FEMY cash_flow (quarterly, 2025-12-31) — Change In Payable: -321574.00
FEMY cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 809553.00
FEMY cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 275738.00
FEMY cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 496902.00
FEMY cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 213520.00
FEMY cash_flow (annual, 2025-12-31) — Change In Receivables: -128227.00
FEMY cash_flow (quarterly, 2025-12-31) — Change In Receivables: -44401.00
FEMY cash_flow (annual, 2025-12-31) — Change In Working Capital: -2056843.00
FEMY cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 363981.00
FEMY cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -128227.00
FEMY cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -44401.00
FEMY cash_flow (annual, 2025-12-31) — Changes In Cash: 5814592.00
FEMY cash_flow (quarterly, 2025-12-31) — Changes In Cash: 4697315.00
FEMY balance_sheet (annual, 2025-12-31) — Common Stock: 59720.00
FEMY balance_sheet (quarterly, 2025-12-31) — Common Stock: 59720.00
FEMY balance_sheet (annual, 2025-12-31) — Common Stock Equity: 5869302.00
FEMY balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 5869302.00
FEMY cash_flow (annual, 2025-12-31) — Common Stock Issuance: 19521989.00
FEMY cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 1516371.00
FEMY balance_sheet (annual, 2025-12-31) — Construction In Progress: 897885.00
FEMY balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 897885.00
FEMY income_statement (annual, 2025-12-31) — Cost Of Revenue: 872400.00
FEMY income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 303125.00
FEMY balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 394863.00
FEMY balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 394863.00
FEMY balance_sheet (annual, 2025-12-31) — Current Assets: 16456335.00
FEMY balance_sheet (quarterly, 2025-12-31) — Current Assets: 16456335.00
FEMY balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 487624.00
FEMY balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 487624.00
FEMY balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 487624.00
FEMY balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 487624.00
FEMY balance_sheet (annual, 2025-12-31) — Current Liabilities: 3636165.00
FEMY balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 3636165.00
FEMY cash_flow (annual, 2025-12-31) — Depreciation: 804281.00
FEMY cash_flow (quarterly, 2025-12-31) — Depreciation: 190712.00
FEMY cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 850456.00
FEMY cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 207423.00
FEMY income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 342034.00
FEMY income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 85199.00
FEMY cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 850456.00
FEMY cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 207423.00
FEMY income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 342034.00
FEMY income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 85199.00
FEMY balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 6957000.00
FEMY balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 6957000.00
FEMY income_statement (annual, 2025-12-31) — Diluted Average Shares: 1977460.00
FEMY income_statement (annual, 2025-12-31) — Diluted EPS: -9.40
FEMY income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -18627887.00
FEMY income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -3950305.00
FEMY income_statement (annual, 2025-12-31) — EBIT: -16735471.00
FEMY income_statement (quarterly, 2025-12-31) — EBIT: -3536723.00
FEMY income_statement (annual, 2025-12-31) — EBITDA: -15885015.00
FEMY income_statement (quarterly, 2025-12-31) — EBITDA: -3329300.00
FEMY cash_flow (annual, 2025-12-31) — End Cash Position: 9266353.00
FEMY cash_flow (quarterly, 2025-12-31) — End Cash Position: 9266353.00
FEMY cash_flow (annual, 2025-12-31) — Financing Cash Flow: 25135255.00
FEMY cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 9079270.00
FEMY balance_sheet (annual, 2025-12-31) — Finished Goods: 2413186.00
FEMY balance_sheet (quarterly, 2025-12-31) — Finished Goods: 2413186.00
FEMY cash_flow (annual, 2025-12-31) — Free Cash Flow: -19320663.00
FEMY cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -4381955.00
FEMY cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -1234000.00
FEMY cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 62650.00
FEMY cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: 9477.00
FEMY income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 1234000.00
FEMY income_statement (annual, 2025-12-31) — General And Administrative Expense: 6646037.00
FEMY income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 1828552.00
FEMY balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 134914.00
FEMY balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 134914.00
FEMY balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 630613.00
FEMY balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 630613.00
FEMY balance_sheet (annual, 2025-12-31) — Gross PPE: 6995636.00
FEMY balance_sheet (quarterly, 2025-12-31) — Gross PPE: 6995636.00
FEMY income_statement (annual, 2025-12-31) — Gross Profit: 1420913.00
FEMY income_statement (quarterly, 2025-12-31) — Gross Profit: 510262.00
FEMY cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 6806.00
FEMY cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 800.00
FEMY income_statement (annual, 2025-12-31) — Interest Expense: 1891119.00
FEMY income_statement (quarterly, 2025-12-31) — Interest Expense: 408097.00
FEMY income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 1891119.00
FEMY income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 408097.00
FEMY income_statement (annual, 2025-12-31) — Interest Income: 101760.00
FEMY income_statement (quarterly, 2025-12-31) — Interest Income: 48272.00
FEMY income_statement (annual, 2025-12-31) — Interest Income Non Operating: 101760.00
FEMY income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 48272.00
FEMY cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 8615.00
FEMY cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 4558.00
FEMY balance_sheet (annual, 2025-12-31) — Inventory: 5740249.00
FEMY balance_sheet (quarterly, 2025-12-31) — Inventory: 5740249.00
FEMY balance_sheet (annual, 2025-12-31) — Invested Capital: 9048166.00
FEMY balance_sheet (quarterly, 2025-12-31) — Invested Capital: 9048166.00
FEMY cash_flow (annual, 2025-12-31) — Investing Cash Flow: -630098.00
FEMY cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -196715.00
FEMY cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 19521989.00
FEMY cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 1516371.00
FEMY cash_flow (annual, 2025-12-31) — Issuance Of Debt: 12000000.00
FEMY balance_sheet (annual, 2025-12-31) — Leases: 1238886.00
FEMY balance_sheet (quarterly, 2025-12-31) — Leases: 1238886.00
FEMY balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 1030476.00
FEMY balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 1030476.00
FEMY balance_sheet (annual, 2025-12-31) — Long Term Debt: 3178864.00
FEMY balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 3178864.00
FEMY balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 4209340.00
FEMY balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 4209340.00
FEMY cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 12000000.00
FEMY cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -7850978.00
FEMY cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -7760017.00
FEMY balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 3561744.00
FEMY balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 3561744.00
FEMY cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 19521989.00
FEMY cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 1516371.00
FEMY income_statement (annual, 2025-12-31) — Net Income: -18627887.00
FEMY income_statement (quarterly, 2025-12-31) — Net Income: -3950305.00
FEMY income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -18627887.00
FEMY income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -3950305.00
FEMY income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -18627887.00
FEMY income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -3950305.00
FEMY income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -18627887.00
FEMY income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -3950305.00
FEMY income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -18627887.00
FEMY income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -3950305.00
FEMY cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -18627887.00
FEMY cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -3950305.00
FEMY income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -18627887.00
FEMY income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -3950305.00
FEMY cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -105091.00
FEMY cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: -56875.00
FEMY income_statement (annual, 2025-12-31) — Net Interest Income: -1789359.00
FEMY income_statement (quarterly, 2025-12-31) — Net Interest Income: -359825.00
FEMY cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 4149022.00
FEMY cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 4239983.00
FEMY cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 4149022.00
FEMY cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 4239983.00
FEMY income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -1789359.00
FEMY income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -359825.00
FEMY cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -1945467.00
FEMY cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -45491.00
FEMY balance_sheet (annual, 2025-12-31) — Net PPE: 3192696.00
FEMY balance_sheet (quarterly, 2025-12-31) — Net PPE: 3192696.00
FEMY cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -525007.00
FEMY cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -139840.00
FEMY balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 5734388.00
FEMY balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 5734388.00
FEMY income_statement (annual, 2025-12-31) — Normalized EBITDA: -17119015.00
FEMY income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -3329300.00
FEMY income_statement (annual, 2025-12-31) — Normalized Income: -19861887.00
FEMY income_statement (quarterly, 2025-12-31) — Normalized Income: -3950305.00
FEMY cash_flow (annual, 2025-12-31) — Operating Cash Flow: -18690565.00
FEMY cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -4185240.00
FEMY cash_flow (annual, 2025-12-31) — Operating Gains Losses: -1171350.00
FEMY cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -1224523.00
FEMY income_statement (annual, 2025-12-31) — Operating Income: -17588669.00
FEMY income_statement (quarterly, 2025-12-31) — Operating Income: -4622728.00
FEMY income_statement (annual, 2025-12-31) — Operating Revenue: 2293313.00
FEMY income_statement (quarterly, 2025-12-31) — Operating Revenue: 813387.00
FEMY balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 2980139.00
FEMY balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 2980139.00
FEMY balance_sheet (annual, 2025-12-31) — Other Current Assets: 833133.00
FEMY balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 833133.00
FEMY balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 52644.00
FEMY balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 52644.00
FEMY balance_sheet (annual, 2025-12-31) — Other Equity Interest: 5246150.00
FEMY balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 5246150.00
FEMY income_statement (annual, 2025-12-31) — Other Gand A: 6646037.00
FEMY income_statement (quarterly, 2025-12-31) — Other Gand A: 1828552.00
FEMY income_statement (annual, 2025-12-31) — Other Income Expense: 751438.00
FEMY income_statement (quarterly, 2025-12-31) — Other Income Expense: 1037733.00
FEMY cash_flow (annual, 2025-12-31) — Other Non Cash Items: 1524914.00
FEMY cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 351761.00
FEMY balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 940232.00
FEMY balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 940232.00
FEMY balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 52370.00
FEMY balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 52370.00
FEMY income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -482562.00
FEMY income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -196267.00
FEMY balance_sheet (annual, 2025-12-31) — Other Properties: 1297121.00
FEMY balance_sheet (quarterly, 2025-12-31) — Other Properties: 1297121.00
FEMY balance_sheet (annual, 2025-12-31) — Payables: 1830124.00
FEMY balance_sheet (quarterly, 2025-12-31) — Payables: 1830124.00
FEMY balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 2224987.00
FEMY balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 2224987.00
FEMY balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 870910.00
FEMY balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 870910.00
FEMY income_statement (annual, 2025-12-31) — Pretax Income: -18626590.00
FEMY income_statement (quarterly, 2025-12-31) — Pretax Income: -3944820.00
FEMY cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 3409711.00
FEMY cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 3368407.00
FEMY balance_sheet (annual, 2025-12-31) — Properties: 0.00
FEMY balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
FEMY cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -105091.00
FEMY cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: -56875.00
FEMY cash_flow (annual, 2025-12-31) — Purchase Of PPE: -525007.00
FEMY cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -139840.00
FEMY balance_sheet (annual, 2025-12-31) — Raw Materials: 2060521.00
FEMY balance_sheet (quarterly, 2025-12-31) — Raw Materials: 2060521.00
FEMY balance_sheet (annual, 2025-12-31) — Receivables: 616600.00
FEMY balance_sheet (quarterly, 2025-12-31) — Receivables: 616600.00
FEMY income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 363978.00
FEMY income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 180901.00
FEMY income_statement (annual, 2025-12-31) — Reconciled Depreciation: 850456.00
FEMY income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 207423.00
FEMY cash_flow (annual, 2025-12-31) — Repayment Of Debt: -7850978.00
FEMY cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -7760017.00
FEMY income_statement (annual, 2025-12-31) — Research And Development: 7577704.00
FEMY income_statement (quarterly, 2025-12-31) — Research And Development: 1812781.00
FEMY balance_sheet (annual, 2025-12-31) — Retained Earnings: -145826144.00
FEMY balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -145826144.00
FEMY income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 4443807.00
FEMY income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 1406458.00
FEMY income_statement (annual, 2025-12-31) — Selling General And Administration: 11089844.00
FEMY income_statement (quarterly, 2025-12-31) — Selling General And Administration: 3235010.00
FEMY balance_sheet (annual, 2025-12-31) — Share Issued: 2986000.00
FEMY balance_sheet (quarterly, 2025-12-31) — Share Issued: 2986000.00
FEMY cash_flow (annual, 2025-12-31) — Stock Based Compensation: 790145.00
FEMY cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 66423.00
FEMY balance_sheet (annual, 2025-12-31) — Stockholders Equity: 5869302.00
FEMY balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 5869302.00
FEMY balance_sheet (annual, 2025-12-31) — Tangible Book Value: 5734388.00
FEMY balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 5734388.00
FEMY income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
FEMY income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
FEMY income_statement (annual, 2025-12-31) — Tax Provision: 1297.00
FEMY income_statement (quarterly, 2025-12-31) — Tax Provision: 5485.00
FEMY income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
FEMY income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
FEMY balance_sheet (annual, 2025-12-31) — Total Assets: 20724177.00
FEMY balance_sheet (quarterly, 2025-12-31) — Total Assets: 20724177.00
FEMY balance_sheet (annual, 2025-12-31) — Total Capitalization: 9048166.00
FEMY balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 9048166.00
FEMY balance_sheet (annual, 2025-12-31) — Total Debt: 4696964.00
FEMY balance_sheet (quarterly, 2025-12-31) — Total Debt: 4696964.00
FEMY balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 5869302.00
FEMY balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 5869302.00
FEMY income_statement (annual, 2025-12-31) — Total Expenses: 19881982.00
FEMY income_statement (quarterly, 2025-12-31) — Total Expenses: 5436115.00
FEMY balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 14854875.00
FEMY balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 14854875.00
FEMY balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 4267842.00
FEMY balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 4267842.00
FEMY balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 11218710.00
FEMY balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 11218710.00
FEMY income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -17588669.00
FEMY income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -4622728.00
FEMY income_statement (annual, 2025-12-31) — Total Unusual Items: 1234000.00
FEMY income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 1234000.00
FEMY balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 5861.00
FEMY balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 5861.00
FEMY balance_sheet (annual, 2025-12-31) — Treasury Stock: 60000.00
FEMY balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 60000.00
FEMY balance_sheet (annual, 2025-12-31) — Work In Process: 1266542.00
FEMY balance_sheet (quarterly, 2025-12-31) — Work In Process: 1266542.00
FEMY balance_sheet (annual, 2025-12-31) — Working Capital: 12820170.00
FEMY balance_sheet (quarterly, 2025-12-31) — Working Capital: 12820170.00
FEMY income_statement (quarterly, 2026-03-31) — +Operating Expense: 4489816.00
FEMY income_statement (quarterly, 2026-03-31) — +Total Revenue: 424889.00
FEMY balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 1597591.00
FEMY balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 172264.00
FEMY balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -3868518.00
FEMY balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 147023279.00
FEMY cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 16692.00
FEMY cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 16692.00
FEMY income_statement (quarterly, 2026-03-31) — Basic Average Shares: 3332279.00
FEMY income_statement (quarterly, 2026-03-31) — Basic EPS: 0.00
FEMY cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 9266353.00
FEMY cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -79138.00
FEMY balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 1392820.00
FEMY balance_sheet (quarterly, 2026-03-31) — Capital Stock: 60508.00
FEMY balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 5386041.00
FEMY balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 5386041.00
FEMY cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 342334.00
FEMY cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -79138.00
FEMY cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -4143508.00
FEMY cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -253439.00
FEMY cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -193226.00
FEMY cash_flow (quarterly, 2026-03-31) — Change In Inventory: -365018.00
FEMY cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -123235.00
FEMY cash_flow (quarterly, 2026-03-31) — Change In Payable: -253439.00
FEMY cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -446665.00
FEMY cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 168722.00
FEMY cash_flow (quarterly, 2026-03-31) — Change In Receivables: 444336.00
FEMY cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -321860.00
FEMY cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 444336.00
FEMY cash_flow (quarterly, 2026-03-31) — Changes In Cash: -3880312.00
FEMY balance_sheet (quarterly, 2026-03-31) — Common Stock: 60508.00
FEMY balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 7289893.00
FEMY cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 352922.00
FEMY balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 955271.00
FEMY income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 158606.00
FEMY balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 271545.00
FEMY balance_sheet (quarterly, 2026-03-31) — Current Assets: 12343489.00
FEMY balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 480286.00
FEMY balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 480286.00
FEMY balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 3155155.00
FEMY cash_flow (quarterly, 2026-03-31) — Depreciation: 183758.00
FEMY cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 200450.00
FEMY income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 82270.00
FEMY cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 200450.00
FEMY income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 82270.00
FEMY balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 1748000.00
FEMY income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 3904781.00
FEMY income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.00
FEMY income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 846100.00
FEMY income_statement (quarterly, 2026-03-31) — EBIT: 1022707.00
FEMY income_statement (quarterly, 2026-03-31) — EBITDA: 1223157.00
FEMY cash_flow (quarterly, 2026-03-31) — End Cash Position: 5386041.00
FEMY cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 342334.00
FEMY balance_sheet (quarterly, 2026-03-31) — Finished Goods: 2472602.00
FEMY cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -4222646.00
FEMY cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -5196413.00
FEMY cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: 0.00
FEMY income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 5196413.00
FEMY income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 1782390.00
FEMY balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 124252.00
FEMY balance_sheet (quarterly, 2026-03-31) — Gross PPE: 6971470.00
FEMY income_statement (quarterly, 2026-03-31) — Gross Profit: 266283.00
FEMY cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 0.00
FEMY income_statement (quarterly, 2026-03-31) — Interest Expense: 176607.00
FEMY income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 176607.00
FEMY income_statement (quarterly, 2026-03-31) — Interest Income: 49827.00
FEMY income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 49827.00
FEMY cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 0.00
FEMY balance_sheet (quarterly, 2026-03-31) — Inventory: 6105267.00
FEMY balance_sheet (quarterly, 2026-03-31) — Invested Capital: 10625069.00
FEMY cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -79138.00
FEMY cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 352922.00
FEMY balance_sheet (quarterly, 2026-03-31) — Leases: 1238886.00
FEMY balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 912534.00
FEMY balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 3335176.00
FEMY balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 4247710.00
FEMY balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 3598372.00
FEMY cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 352922.00
FEMY income_statement (quarterly, 2026-03-31) — Net Income: 846100.00
FEMY income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 846100.00
FEMY income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 846100.00
FEMY income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 846100.00
FEMY income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 846100.00
FEMY cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 846100.00
FEMY income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 846100.00
FEMY income_statement (quarterly, 2026-03-31) — Net Interest Income: -126780.00
FEMY income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -126780.00
FEMY cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -10588.00
FEMY balance_sheet (quarterly, 2026-03-31) — Net PPE: 3102952.00
FEMY cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -79138.00
FEMY balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 7165641.00
FEMY income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -3973256.00
FEMY income_statement (quarterly, 2026-03-31) — Normalized Income: -4350313.00
FEMY cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -4143508.00
FEMY cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -5196413.00
FEMY income_statement (quarterly, 2026-03-31) — Operating Income: -4223533.00
FEMY income_statement (quarterly, 2026-03-31) — Operating Revenue: 424889.00
FEMY balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 3019534.00
FEMY balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 679917.00
FEMY balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 52572.00
FEMY balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 5246150.00
FEMY income_statement (quarterly, 2026-03-31) — Other Gand A: 1782390.00
FEMY income_statement (quarterly, 2026-03-31) — Other Income Expense: 5196413.00
FEMY cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 176607.00
FEMY balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 924552.00
FEMY balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 54487.00
FEMY balance_sheet (quarterly, 2026-03-31) — Other Properties: 1178941.00
FEMY balance_sheet (quarterly, 2026-03-31) — Payables: 1597591.00
FEMY balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 1869136.00
FEMY balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 753161.00
FEMY income_statement (quarterly, 2026-03-31) — Pretax Income: 846100.00
FEMY balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
FEMY cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -79138.00
FEMY balance_sheet (quarterly, 2026-03-31) — Raw Materials: 2048291.00
FEMY balance_sheet (quarterly, 2026-03-31) — Receivables: 172264.00
FEMY income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 40426.00
FEMY income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 200450.00
FEMY income_statement (quarterly, 2026-03-31) — Research And Development: 1309401.00
FEMY balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -144980044.00
FEMY income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 1315755.00
FEMY income_statement (quarterly, 2026-03-31) — Selling General And Administration: 3098145.00
FEMY balance_sheet (quarterly, 2026-03-31) — Share Issued: 3025395.00
FEMY cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 151608.00
FEMY balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 7289893.00
FEMY balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 7165641.00
FEMY income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
FEMY income_statement (quarterly, 2026-03-31) — Tax Provision: 0.00
FEMY income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
FEMY balance_sheet (quarterly, 2026-03-31) — Total Assets: 16495245.00
FEMY balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 10625069.00
FEMY balance_sheet (quarterly, 2026-03-31) — Total Debt: 4727996.00
FEMY balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 7289893.00
FEMY income_statement (quarterly, 2026-03-31) — Total Expenses: 4648422.00
FEMY balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 9205352.00
FEMY balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 4151756.00
FEMY balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 6050197.00
FEMY income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -4223533.00
FEMY income_statement (quarterly, 2026-03-31) — Total Unusual Items: 5196413.00